Choosing a chromatography column isn't only about scale, the purification application and the chromatography resin being used can significantly influence the requirements placed on the column.

Different purification challenges require different selectivity, flow characteristics, operating conditions and approaches to scale-up. At the same time, physical properties of the chromatography resin can affect packing, operating pressure and chromatographic performance.

Considering the resin and column together can therefore help establish a more robust purification process.

Recombinant protein purification

Recombinant protein purification typically involves multiple chromatography steps, beginning with a high-selectivity capture stage followed by intermediate purification and polishing.

As the process moves from laboratory development towards manufacturing, maintaining consistent chromatographic performance becomes increasingly important.

Typical considerations include:

• High dynamic binding capacity
• Consistent flow distribution
• Reproducible bed packing
• Straightforward scale-up

Astrea Bioseparations chromatography resins for recombinant protein purification can be paired with SNAP®, Evolve®R or Evolve®D Columns, depending on the stage of development and manufacturing strategy.

Solutions include PuraBead^® Affinity resins for capture together with MiMode^® mixed-mode resins for intermediate purification and polishing, providing options across the purification workflow.

Cell and gene therapy purification

Cell and gene therapy manufacturing can present different downstream purification challenges, including the processing of viral vectors, plasmid DNA, extracellular vesicles and other advanced therapy products.

These processes require chromatography solutions capable of supporting high product recovery and efficient impurity removal while providing a route from development into GMP manufacture.

Key considerations can include:

• High product recovery
• Removal of host cell proteins, host cell DNA and other process-related impurities
• Scalability from process development through GMP manufacture
• Flexible platforms for smaller manufacturing batches

Astrea Bioseparations offers specialised purification technologies for advanced therapy applications, including AstreaAdept^® nanofiber technology, Q PuraBead^® and DEAE PuraBead^® resins.

These can be paired with scalable column platforms throughout development and manufacturing. SNAP® Columns can support method optimization and process characterization, while Evolve®S provides a ready-to-use platform for engineering studies, process transfer and smaller-scale GMP manufacture. Evolve®D and Evolve® Process Columns can support larger-scale requirements.

Polishing chromatography

Polishing removes residual process- and product-related impurities to achieve the required final product quality.

These impurities can include host cell proteins, DNA, endotoxins and aggregates. Because polishing separations can depend on relatively small differences in molecular properties, consistent bed packing and uniform flow distribution are particularly important.

Considerations include:

• High chromatographic resolution
• Efficient impurity removal
• Uniform flow distribution
• Reproducible packed beds
• Consistent performance during scale-up

Astrea Bioseparations polishing solutions include SP PuraBead^® Edge and Q PuraBead^® Edge ion exchange resins, alongside EtoxiClear^® for targeted endotoxin removal.

Depending on the stage and scale of the process, these can be combined with SNAP®, Evolve®R, Evolve®D or Evolve® Process Columns.

Plasma protein purification

Purification of plasma-derived therapeutics requires robust chromatography systems capable of supporting repeated manufacturing campaigns while maintaining consistent purification performance.

As process volumes increase, reliable column performance, reproducible packed beds and scalable hardware become increasingly important.

Astrea Bioseparations solutions include Mimetic Blue^®, which supports albumin removal during plasma fractionation, and IsoClear^® XT, an immunoaffinity resin developed for immunoglobulin G (IVIG) purification.

For laboratory process development, these resins can be paired with SNAP® and Evolve® R Columns. Evolve®D pre-packed columns and Evolve® Process self-packing columns provide options as processes move towards pilot and manufacturing scales.

How do resin properties affect column selection?

The purification application tells you what the separation needs to achieve. The resin itself helps determine what the chromatography column needs to accommodate.

Three areas deserve particular attention:

1. Particle size

Smaller resin particles generally provide higher resolution and greater separation efficiency. However, they can also generate greater back pressure and can be more sensitive to poor packing.

Larger particles generally allow higher flow rates, lower operating pressures and easier packing.

2. Resin rigidity

Rigid chromatography media generally tolerate higher packing forces and operating flow rates.

Softer matrices may require more controlled packing procedures to maintain bed integrity and chromatographic performance.

3. Chromatography mode

The chromatography mode can also influence requirements for operating pressure, bed height, flow rate and resolution.

This includes techniques such as:

• Affinity chromatography
• Mixed-mode chromatography
• Ion exchange chromatography
• Hydrophobic interaction chromatography
• Size exclusion chromatography

Consider the column and resin together

Rather than selecting a resin and treating the chromatography column as a separate hardware decision, consider how the two will operate together under your intended process conditions.

Ask what the purification needs to achieve, what properties the selected resin brings to the process and what demands that combination places on the column.

Taking this combined approach can help maximise purification performance while creating a smoother pathway from laboratory development towards manufacturing.